A combined MRI-PSAD risk stratification system for prioritizing prostate biopsies.

Noam Bar-YaakovZiv SavinIbrahim FahoumSophie BarnesYuval Bar-YosefOfer YossepowitchGal Keren-PazRoy Mano

Published in: The Canadian journal of urology (2024)

Our findings suggest that a three-tier risk classification system based on mpMRI and PSAD can identify patients at high-risk for CSPC who may benefit from earlier biopsy.

Keyphrases

end stage renal disease
prostate cancer
ejection fraction
newly diagnosed
chronic kidney disease
magnetic resonance imaging
ultrasound guided
peritoneal dialysis
contrast enhanced
patient reported